Glyceryl monocaprylate/caprate as a moderate skin penetration enhancer

International Journal of Pharmaceutics

Volumn 171, Issue 2, 1998, Pages 243-255

  Cornwell, Paul A ^a   Tubek, Joe ^a   Van Gompel, Hans A H P ^a   Little, Chris J ^a   Wiechers, Johann W ^a  

^a Unichema International   (Netherlands)

Author keywords

5 Fluorouracil; Azone ; Fatty acid ester; Penetration enhancer; Structure activity relationship

Indexed keywords

FATTY ACID ESTER; FLUOROURACIL; LAUROCAPRAM; OCTANOIN; PENETRATION ENHANCING AGENT;

ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG MIXTURE; DRUG PENETRATION; DRUG STRUCTURE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; PRIORITY JOURNAL; SKIN PENETRATION; STRATUM CORNEUM; STRUCTURE ACTIVITY RELATION; TOPICAL DRUG ADMINISTRATION;

EID: 0032531328     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(98)00194-X     Document Type: Article

References (31)

1. Aungst B.J., Rogers N.J., Shefter E. Enhancement of naloxone penetration through human skin in vitro using fatty acids, fatty alcohols, surfactants, sulfoxides and amides. Int. J. Pharm. 33:1986;225-234.
2. Barry, B.W., 1987. Penetration enhancers: mode of action in human skin. In: Shroot, B., Schaefer H. (Eds.), Pharmacology and the Skin, vol. 1. Karger, Basel, pp. 121-137.
3. Barry, B.W., 1991. The LPP theory of skin penetration enhancement. In: Bronaugh, R.L., Maibach, H.I. (Eds.), In Vitro Percutaneous Absorption: Principles, Fundamentals and Applications. CRC Press, Boca Raton, FL, pp. 165-185.
4. Blank I.H. Further observations on factors which influence the water content of the stratum corneum. J. Invest. Dermatol. 21:1953;259-269.
5. Bond J.R., Barry B.W. Limitations of hairless mouse skin as a model for in vitro permeation studies through human skin: hydration damage. J. Invest. Dermatol. 90:1988;486-489.
6. Bouwstra J.A., Peschier L.J.C., Brussee J., Boddé H.E. Effect of N-alkyl-azocycloheptan-2-ones including azone on the thermal behaviour of human stratum corneum. Int. J. Pharm. 52:1989;47-54.
7. Bouwstra J.A., Gooris G.S., Brussee J., Salomons-de Vries M.A., Bras W. The influence of alkyl-azones on the ordering of the lamellae in human stratum corneum. Int. J. Pharm. 79:1992;141-148.
8. Bronaugh R.L., Stewart R.F. Methods for in vitro percutaneous absorption studies IV: The flow-through diffusion cell. J. Pharm. Sci. 74:1985;64-67.
9. Chukwumerije O., Nash R.A., Matias M.S., Orentreich N. Studies on the efficacy of methyl esters of n-alkyl fatty acids as penetration enhancers. J. Invest. Dermatol. 93:1989;349-352.
10. Cornwell, P.A., Barry, B.W., 1992. The effects of a series of homologous terpene alcohols on the lipid structure of human stratum corneum as assessed by differential scanning calorimetry. In: Scott, R.C., Guy, R.H., Hadgraft, J. (Eds.), Prediction of Percutaneous Penetration, vol. 2. IBC Technical Services, pp. 394-400.
11. Cornwell P.A., Barry B.W. Sesquiterpene components of volatile oils as skin penetration enhancers for the hydrophilic permeant 5-fluorouracil. J. Pharm. Pharmacol. 46:1994;261-269.
12. Cornwell P.A., Barry B.W. Effects of penetration enhancer treatment on the statistical distribution of human skin permeabilities. Int. J. Pharm. 117:1995;101-112.
13. Cornwell P.A., Barry B.W., Bouwstra J.A., Gooris G.S. Modes of action of terpene penetration enhancers in human skin; differential scanning calorimetry, small-angle X-ray diffraction and enhancer uptake studies. Int. J. Pharm. 127:1996;9-26.
14. Davies, J.T., Rideal, E.K., 1963. Interfacial Phenomena. Academic Press, New York, pp. 343-450.
15. Elias P.M. Epidermal barrier function: intercellular lamellar lipid structures, origin, composition and metabolism. J. Control. Release. 15:1991;199-208.
16. Goodman M., Barry B.W. Action of penetration enhancers on human skin as assessed by the permeation of model drugs 5-fluorouracil and estradiol. I. Infinite dose technique. J. Invest. Dermatol. 91:1988;323-327.
17. Hadgraft, J., Williams, D.G., 1993. Azone. Mechanisms of action and clinical effect. In: Walters, K.A., Hadgraft, J. (Eds.), Pharmaceutical Skin Penetration Enhancement. Marcel Dekker, New York, pp. 175-197.
18. Hoogstraate A.J., Verhoef J., Brussee J., IJzerman A.P., Spies F., Boddé H.E. Kinetics, ultrastructural aspects and molecular modelling of transdermal peptide flux enhancement by N-alkyl-azacycloheptanones. Int. J. Pharm. 76:1991;37-47.
19. Hori M., Maibach H.I., Guy R.H. Enhancement of propranolol hydrochloride and diazepam skin absorption in vitro. II: Vehicle, and enhancer penetration kinetics. J. Pharm. Sci. 81:1992;330-333.
20. Leopold C.L., Lippold B.C. An attempt to clarify the mechanism of the penetration enhancing effects of lipophilic vehicles with differential scanning calorimetry (DSC). J. Pharm. Pharmacol. 47:1995;276-281.
21. Monash S., Blank I.H. Location and reformation of the epithelial barrier to water vapour. Arch. Dermatol. 78:1958;710-714.
22. Nakamura H., Pongpaibul Y., Hayashi T., Sugibayashi K., Morimoto Y. Effect of lipophilic multicomponent system on the skin permeation of ketotifen fumarate. Int. J. Pharm. 141:1996;71-80.
23. Okumura M., Sugibayashi K., Morimoto Y. Effect of several enhancers on the skin permeation of water-soluble drugs. Chem. Pharm. Bull. 37:1989;1375-1378.
24. Ongpipattanakul B., Burnette R.R., Potts R.O., Francoeur M.L. Evidence that oleic acid exists in a separate phase within stratum corneum lipids. Pharm. Res. 8:1991;350-354.
25. Ozawa Y., Yamahira T., Sunnada H., Nadai T. Influence of fatty acid-alcohol esters on percutaneous absorption of hydrocortisone butyrate propionate. Chem. Pharm. Bull. 36:1988;2145-2151.
26. Scheuplein R.J. Mechanisms of percutaneous absorption I. Routes of penetration and the influence of solubility. J. Invest. Dermatol. 43:1965;334-346.
27. Smith, E.W., Maibach, H.I. (Eds.), 1995. Percutaneous Penetration Enhancers. CRC Press, Boca Raton, FL.
28. Suzuki T., Kudo Y. Automatic log P estimation based on combined additive modelling methods. J. Comput.-Aided Mol. Design. 4:1990;155-198.
29. Wiechers J.W., De Zeeuw R.A. Transdermal drug delivery: efficacy and potential applications of the penetration enhancer Azone® Drug Des. Deliv. 6:1990;87-100.
30. Williams A.C., Barry B.W. Terpenes and the lipid-protein-partitioning theory of skin penetration enhancement. Pharm. Res. 8:1991;17-24.
31. Williams A.C., Cornwell P.A., Barry B.W. On the non-Gaussian distribution of human skin permeabilities. Int. J. Pharm. 86:1992;69-77.